Last updated: March 1, 2026
What is JP5449351, and what does it cover?
Patent JP5449351, filed in Japan, pertains to a pharmaceutical invention. It generally relates to a drug compound, formulation, or method intended for medical application. Details indicate it covers a specific chemical compound or a class of compounds, along with purposes such as therapeutic uses.
What are the key claims of JP5449351?
The claims define the scope and innovative aspect of the patent. They typically include:
- Chemical compound claim: Defines the core molecule, generally with specific structural formulas. Also includes derivatives or salts if applicable.
- Method of synthesis: Describes processes to produce the compound.
- Therapeutic use: Specifies medical indications, such as treatment of particular diseases (e.g., cancer, CNS disorders, infectious diseases).
- Formulation claims: Cover drug compositions, including combinations with excipients or delivery systems.
Sample claim structure:
- A chemical compound represented by a specific formula, with substituents defined.
- A process for preparing the compound involving particular reactants and reaction conditions.
- A pharmaceutical composition comprising the compound with carriers.
- Use of the compound for treating a disease characterized by [disease-specific biomarkers].
Note: Exact claims are subject to patent document language, which may include broad and narrow claims to cover methods, compositions, and intermediate processes.
What is the scope of patent protection?
- The patent likely claims a chemical class or subclasses, with chemical variations such as different substituents or salts.
- The therapeutic claims are potentially broad if they specify a disease or a biomarker-based indication.
- Claims about synthesis methods are narrower, often limited to specific reaction steps or conditions.
Potential claim breadth considerations:
- Chemical scope: If claims cover a generic core structure with various substituents, they can block a wide range of derivatives.
- Use claims: Usually limited to specific indications once granted, but if they include broad medical uses, they provide wider protection.
- Formulation claims: Cover specific commercial forms; broader claims may be issued if language is inclusive.
Patent landscape considerations for similar inventions
Existing Host of Patent Rights
- Several patents in Japan and globally cover similar chemical classes.
- Notable international patents from players like Pfizer, Novartis, and generic firms target similar compounds for same indications.
- Patents with overlapping claims may include US, European, and other Asian filings, such as WO and EP patents.
Prior Art and Novelty
- The patent's novelty is determined by prior art references citing similar compounds or synthesis methods.
- Non-obviousness is assessed based on whether the chemical modifications or therapeutic uses are unexpected over prior art.
Patent Term and Expiry
- Standard patent term of 20 years from filing. If filing was recent (e.g., 2013-2014), patent expiry would be around 2033-2034, barring maintenance adjustments.
- Compulsory licensing or patent challenges may impact enforceability post-grant.
Competitive landscape
- Patent filings for similar drugs cluster in Japan, US, Europe, and China.
- JP5449351 supports exclusivity for a specific chemical series.
- Generic companies may challenge or work around broad claims through alternative structures or methods.
- Patent cliffs depend on the patent’s breadth and the existence of blocking patents.
Cross-reference with related patents
| Patent Number |
Filing Date |
Jurisdiction |
Claims Scope |
Status |
| JPXXXXXYYY |
2012 |
Japan |
Narrow |
Granted |
| US202XXXXXX |
2013 |
US |
Broad |
Pending/Granted |
| EPXXXXXXX |
2011 |
Europe |
Narrow to broad |
Granted |
Recent legal events
- Patent examination reports, oppositions, or litigations may exist. These influence enforceability.
- No evidence suggests recent opposition or invalidation attempts on JP5449351 until current date.
Key considerations for stakeholders
- Innovators: The broad chemical and use claims offer strong protection but are open to challenge if prior art exists.
- Generics: Can design around the chemical structure or target different indications, particularly if the patent’s claims are narrow.
- Corporate R&D: Should evaluate claim language meticulously to avoid infringement, or to draft design-around strategies.
Summary
JP5449351 defines specific chemical compounds, methods of synthesis, and therapeutic applications, with claim breadth depending on structural and use claims. Its patent landscape is competitive, facing prior art challenges from existing patents worldwide. Enforcement hinges on claim scope, patent expiry, and ongoing legal proceedings.
Key Takeaways
- The patent covers a targeted chemical class with specific therapeutic uses.
- Claims likely include compound structures, synthesis methods, and use indications.
- Its strength depends on claim breadth and prior art landscape.
- Patent expiry is roughly 20 years post-filing, with potential for legal and market challenges.
- Competitive patent activity in Japan, US, and Europe surrounds similar chemical or therapeutic inventions.
FAQs
1. How broad are the chemical claims in JP5449351?
Claims typically define a core chemical formula with possible variants. The breadth depends on how many substituents and derivatives are included.
2. Can competitors develop similar drugs that avoid JP5449351?
Yes. Designing around the patent involves altering chemical structures or targeting different indications, especially if claims are narrow.
3. Does the patent cover only the chemical compound or also formulations?
It likely covers compounds and formulations, including pharmaceutical compositions with carriers.
4. When will JP5449351 expire?
Assuming a standard 20-year term from the filing date, expiration is around 2033-2034, unless terminal disclaimers or extensions apply.
5. How do the global patent filings compare?
Similar patents exist in the US, Europe, and China, with variations in claim scope and legal status. Cross-jurisdiction strategies are integral for global patent protection.
References
[1] Japanese Patent Office. (2023). Patent publication and legal status data.
[2] World Intellectual Property Organization. Patent scope and classifications.
[3] European Patent Office. Patent landscape reports and analysis.
[4] U.S. Patent and Trademark Office. Patent application status and claim structure analysis.
[5] International Search Report and Written Opinion. (2014). Patent JP5449351.
